Skip to content
HowShorted

Quince Therapeutics, Inc. short interest in 2021

In 2021, Quince Therapeutics, Inc.'s disclosed short interest ran from 9.56% of shares outstanding on 15 Jan 2021 to 29.70% on 31 Dec 2021, a change of +20.14 percentage points. The year's high was 30.75% on 30 Nov 2021 and its low 8.59% on 13 Aug 2021, averaging 14.36% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.00 days on 14 May 2021. Full history: Quince Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Quince Therapeutics, Inc. in 2021

2021 in figures

Start of year
9.56% (15 Jan 2021)
End of year
29.70% (31 Dec 2021)
Change
+20.14 pp
High
30.75% (30 Nov 2021)
Low
8.59% (13 Aug 2021)
Average
14.36%
Highest days to cover
25.00 (14 May 2021)
SEC filings marked
5

Every report in 2021

Quince Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20219.56%21.49
29 Jan 20219.45%11.47results (8-K)
12 Feb 20219.21%9.04
26 Feb 202111.06%6.83
15 Mar 202110.93%11.5010-K filed
31 Mar 202113.23%12.44
15 Apr 202112.40%15.56
30 Apr 202112.41%20.63
14 May 202112.80%25.0010-Q filed
28 May 202112.02%23.08
15 Jun 202112.01%15.91
30 Jun 202110.30%11.74
15 Jul 20219.69%13.63
30 Jul 202110.08%17.46
13 Aug 20218.59%4.7710-Q filed
31 Aug 20218.90%10.05
15 Sep 20218.91%12.89
30 Sep 20218.78%11.06
15 Oct 20218.71%8.87
29 Oct 202126.57%1.5210-Q filed
15 Nov 202130.30%2.16
30 Nov 202130.75%7.42
15 Dec 202128.21%6.00
31 Dec 202129.70%6.86

See also: Quince Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.